| Identification | Back Directory | [Name]
N-[2-(4-sulfamoylphenyl)ethyl]-2-thiophen-2-ylquinoline-4-carboxamide | [CAS]
687576-28-9 | [Synonyms]
N-(4-Sulfamoylphenethyl)-2-(thiophen-2-yl)quinoline-4-carboxamide
N-[2-(4-sulfamoylphenyl)ethyl]-2-thiophen-2-ylquinoline-4-carboxamide
4-Quinolinecarboxamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-2-(2-thienyl)- | [Molecular Formula]
C22H19N3O3S2 | [MDL Number]
MFCD05999926 | [MOL File]
687576-28-9.mol | [Molecular Weight]
437.53 |
| Hazard Information | Back Directory | [Uses]
ROS kinases-IN-2 is a ROS kinase inhibitor with 21.53% inhibition at 10 μM[1]. | [References]
[1] Dorre A. GRUENEBERG, et al. Novel methods, compounds, and compositions for inhibition of ros. Patent WO2014141129A2. |
|
| Company Name: |
OTAVA chemicals
|
| Tel: |
416 305 9979 (Canada) |
| Website: |
www.otavachemicals.com |
| Company Name: |
PHARMEKS Ltd.
|
| Tel: |
+7 (495) 702-9648 |
| Website: |
www.pharmeks.com |
|